Munich 2017

The Global Alliance for Patient Access (GAfPA) and the European Federation of Crohn’s and Colitis Associations (EFCCA) came together to hold a Biologics and Biosimilars Patient Access and Advocacy Workshop in Munich, Germany on May 4-5, 2017. The 17 attendees from 13 different countries represented specialities from across rheumatology, gastroenterology and neurology, including several members of EFCCA’s European network.

The workshop built upon the successful events held by GAfPA and EFCCA in 2016 in Barcelona and Brussels, bringing together patient representatives, physicians and healthcare professionals from across Europe to consider policy questions around the use of biologic and biosimilar medicines. Discussion touched on patient access, use of biological medicines, and how to most effectively ensure that the patient voice informs policy decisions.

Click here to download the Munich Workshop Report!